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SUMMARY
Background. Asthma and COPD are common diseases of 
the airways which are mainly diagnosed and treated in 
general practice.
Aim. Various studies have reported an increase in the mor­
bidity o f asthma and COPD. There are two possible reasons 
for such an increase. The firs t is an apparent increase 
caused by using different criteria in defining asthma/COPD, 
and by increased awareness of the disease by doctors and 
patients. The second is a real increase caused by an 
increase in the prevalence of airway pathology. The aim of 
this study was to determine the cause o f the observed 
increase in morbidity.
Method. In 1977, a sample o f 2328 adults from the general 
population were screened for asthma and COPD. Those 
screened were then divided into five sub-groups (grades
Introduction
STHMA and COPD are common chronic diseases of the air­
ways that are mainly diagnosed and treated in general prac­
tice. In the Dutch health-care system, every inhabitant is regis­
tered at a local general practice. The general practitioner (GP) is 
the provider of basic medical care to an average of 2500 people 
and is the gateway to specialized care. Therefore, it is important 
that each GP knows the population in their practice.
The prevalence of asthma and COPD in the general population 
has been compared to an iceberg. The visible part of the iceberg 
represents patients known to either the GP or the pulmonologist 
and specialized asthma centres (registered morbidity). The sub­
merged part represents people with respiratory symptoms and 
other objective signs of asthma and COPD who are not known to 
the health-care system but who are detected during screening 
surveys. Its numbers result from under-diagnosis' and under-pre­
sentation  by the patient. This un d er-p resen ta tio n  may be 
explained by the absence of a good correlation between respira­
tory symptoms and lung function.2
Various studies have reported an increase in the morbidity and 
mortality of asthma.3"6 This is alarming, especially with the 
abundance of adequate treatment currently available. It is diffi-
. 7■“ases. The use of various definitions has been shown to be a
8
1-5), according to severity of: (1) respiratory symptoms; cult to assess the incidence and prevalence of chronic respiratory 
and (2) loss in FEVu The number o f patients who were not 
known to the general practitioner prior to the screening as 
having asthma or COPD grades 1-5 were also assessed. In 
1992, we studied a different sample o f 1184 adults of the 
general population in the same area. We used the same cri-
probable cause for this discrepancy in prevalence data, 
cent age of patients not known to the GP also varies for the differ­
ent studies and can be assumed to be because of the same reason. 
Therefore, it is important to know whether the increase in preva- 
teria as in 1977 to analyse our results. The number o f lence is caused by a real increase in the pathology of the airways,
patients not known to the general practitioner prior to the 
screening was also studied.
Results. The overall prevalence (grades 1-5) of asthma and 
COPD has increased from ± 19% in 1977 to ± 31% in 1992 
(range 21-42). The main reason for this is an increase in 
prevalence o f very m ild to moderate asthma and COPD 
(grades 1-3) from 17% in 1977 to 27% in 1992. The preva­
lence o f severe cases (grades 4-5) increased from 2% in 
1977 to 4% in 1992. In 1992, around 65% of the patients 
were not known to the general practitioner as having any 
grade o f asthma or COPD. This was only slightly lower than 
the 72% in 1977. All patients with a severe disease (grade 5) 
were known to the general practitioner.
Conclusions. There is a real increase in the prevalence of 
asthma and COPD, caused predominantly by an increase in 
the number of mild cases. The percentage of patients not 
known to the GP were predominantly mild cases.
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or whether it is an apparent increase caused by better means of 
detection or merely reflects a change in diagnostic criteria 
applied. This is summarized in Figure 1. Figure 1A shows the 
situation several years ago, with the tip and the submerged parts 
of the iceberg representing the detected and undetected cases, 
respectively. Figure IB represents a possible explanation for the 
increase in morbidity by increased awareness on the part of the 
doctor and patient, or by better methods of detection. In this case, 
a decrease in the percentage of persons not known to the GP 
could be expected owing to an upward shift of the iceberg. 
Another possible explanation for the increase in morbidity is 
shown in Figure 1C; in this case, it results from an overall 
increase in the prevalence of asthma and COPD.
The aim of this study was to investigate the prevalence of asth­
ma/COPD and the percentage of adult patients currently not 
known to the GP compared with that of several years ago. We 
investigated this by means of a screening survey conducted in 
1992 and a comparison of the results with a screening survey 
conducted in 1977. The results o f  the survey in 1992 were 
analysed by the same criteria used in 1977.
Methods
This study is a comparison between a population survey (screen­
ing) for asthma/COPD in 1992 and a population survey in 
performed in the same suburban region of the eastern part of 
Netherlands,
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Population survey in 1992
In 1992, we screened a sample of the adult population from the 
sex-age register of 10 general practices (city and rural) around 
the city of Nijmegen, the Netherlands, for symptoms and signs of 
asthma and COPD. This was the initial stage of a longitudinal
ratory manoeuvres from maximum inspiration. The FEV| corre­
sponding to the manoeuvre with the highest sum of the FEVi and 
FVC was recorded as the FEVi at that moment.
The degree o f reversibility o f  the airway obstruction
study conducted by the Departments of General Practice and The subject was administered 800 p g salbutamol by inhalation, 
Pulmonology of the University of Nijmegen on the early detec- immediately after the base-line measurements. The FEVi was 
tion, monitoring, and intervention of asthma and COPD in gener­
al practice (DIMCA project). The respective GPs were then
asked to exclude all persons who fulfilled at least one of the live 
exclusion criteria: congestive heart failure, lung disease other
measured again after 15 min. The degree of reversibility was 
defined as the change in FEVi as a percentage of the predicted
value.11
than asthm a/C O PD , serious m orbidity  with reduced life- Patient characteristics of persons already diagnosed 
expectancy, or severe physical or mental handicap. Patients with treated by the general practitioner 
asthma/COPD dependent on corticosteroids were also excluded 
from the screening. This last group was further included in the 
analyses of the present study. All other subjects were invited to
take part in this survey. Those not responding to the first letter 
were sent a reminder. The screening took place at the office of 
the respective GP and was done by investigators who had under­
gone prior training in administering questionnaires and testing 
lung function. All participants gave their consent in writing after 
being fully informed of the study.
Recruitment bias
In order to investigate the presence of a recruitment bias, a ran­
dom sample of persons who refused to take part in the study were 
asked to consider taking a simplified version of the screening test 
at their own homes. Most patients refused to take part initially 
because of the use of bronchodilators (medication) during the 
reversibility test and the inconvenience caused by having to visit 
the office of the general practitioner for the screenings test.
Respiratory symptoms and lung function
Symptoms were assessed by means of a modified Dutch version 
of the MRC questionnaire.1>
The FEVi was measured by means of a portable Microspiro 
HI-298 (Chest corporation, Tokyo, Japan).10 After sufficient 
instructions, the subject was asked to perform three forced expi-
We analysed various patient characteristics, such as age, gender 
and lung function, of people who had been diagnosed by the GP 
at the time of the screening, and who were using non-steroidal 
medication for asthma/COPD. The patients on steroids (excluded 
from screening) were not considered for this analysis as this 
medication might have influenced the medical status of these 
patients. We compared the patient characteristics of those using 
(non-steroidal) medication with that of patients not using med­
ication in order to learn more about the type of patient the GP 
considers in need of medication.
Comparison with survey in 1977 and analysis
A survey by Huygen et al on asthma and COPD, published in 
1977, served as a comparison.12 This survey included patients 
above the age of 6 years (n = 4623), registered in one general 
practice, and followed a two-step approach. First, all participants 
had to complete a five-item questionnaire enquiring about short­
ness of breath, cough and phlegm production, wheezing, and 
asthma attacks. Those with at least one positive answer were 
invited for a follow-up study which consisted of a respiratory 
symptoms questionnaire9,12 and a lung function test (FEVi), All 
participants were then divided into six groups (grades 0-5) 
according to the severity of symptoms and the deficit in FEV|,y 
which were accepted Dutch criteria at that time (Table 1). The 
prevalence of the different grades of asthma/COPD were report-
(B) increase in prevalence by improved detection, and
(C) real increase in prevalence.
Table 1. A summary of the criteria of severity of asthma/COPD 
used in 1977. The results of the 1992 survey were analysed with 
the same criteria.*
dU
Severity Symptoms and signs
MU****""
Grade 0 Respiratory symptoms absent
(chronic cough, chronic expectoration, dyspnoea, 
wheezing, asthma attacks, episode of bronchitis) 
and FEVi > 95% predicted value
Grade 1 At least one of the above symptoms positive
and FEVt > 95% predicted value
Grade 2 At least 1 of the above symptoms positive
or FEVi 85-95% predicted value
Grade 3 Grade 1 symptoms and FEVi > 95% predicted
value or FEVi < 85% predicted value
Grade 4 Grade 1 symptoms and FEVi 75-90%
predicted value
Grade 5 Grade 1 symptoms and FEVi < 75%
predicted value
*FEVi, forced expiratory volume in 1 s.
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eil along wilh the rate of cases diagnosed before in routine gener­
al practice care.
For the purpose of this study, the data from the 1977 survey 
were restricted to adult subjects between 25 and 70 years of age 
(/i = 2328). The 1992 questionnaire contained all questions used 
in 1977. The data were analysed in the same two-step manner as 
performed in 1977 and expressed in the six degrees of severity. 
All patients in the 1992 sample on maintenance corticosteroid 
treatment were included in the present study and allocated to 
severity degree 5. We compared the prevalence, severity and per­
centage of cases diagnosed in routine general practice care in
1992 and 1977.
Moderate cases (grade 3) accounted for 68/1000 and a preva­
lence of 35 was found for severe cases (grades 4 and 5).
Percentage of persons with asthma/COPD grades 1-5 
who were not known to the general practitioner in 1992
Out of the 362 cases identified at the survey, 65% had not been 
diagnosed before in general practice (Table 4). For the mild 
(grades 1-2) and moderate (grade 3) cases, this was 73 and 70%, 
respectively. Most of the severe cases (grades 4 and 5) had 
already been diagnosed: a l'irst-time diagnosis was made in only 
1%. No new cases with a severity grade 5 were found.
The differences between patients using medication (non-corticos­
teroid) and those not using any medication was tested by means 
of the unpaired Student’s /-test (normally distributed variables) 
or by the (%2 test (class variables). P-values less than 0.05% were 
considered significant.
The 95% confidence intervals were calculated for the preva­
lence of asthma/COPD for the sample in 1977 and the 10 samples 
in 1992. Chi-squared tests for proportion were applied to compare 
the prevalence of each sample in 1992 with that in 1977.
Comparison o f 1992 and 1977
The total prevalence of asthma/COPD in 1992 was substantially
Results
Population survey in 1992
One thousand nine hundred and eighty-eight subjects of ages 
25-70  years were randomly selected from the 10 practices 
(Table 2). The general practitioners excluded 239 (12%) on 
basis of the exclusion criteria; 29 out of the 239 subjects were 
excluded because of the use of inhaled corticosteroids for their 
asthma/COPD. In total, 1749 subjects were invited, of whom 
1155 (66%) consented to participate in this survey. The 29 
patients using inhaled-steroids for asthma/COPD were also con­
sidered for analysis. They had been excluded from screening 
because steroids are known to alter the normal course of lung 
function and symptoms in patients. These patients had previous­
ly been diagnosed and treated by the respective GP. Therefore, 
the total study population consisted of 1184 subjects.
Recruitment-bias
We found 34 randomly chosen non-participants who were will­
ing to take the simplified version of the screening test. The 
demographic and clinometric characteristics of the non-partici­
pants were compared with that of the participants. There were no 
significant differences between the two groups.
Patient characteristics o f persons previously diagnosed 
and treated by the general practitioner
There were 58 sub jec ts  who were u n d e r  t re a tm e n t  fo r 
asthma/COPD. Twenty-nine had been excluded from screening 
on the grounds of corticosteroid dependency, and 29 of the total 
screened were receiving non-steroid treatment (Table 3). This 
last group did not differ from the total sample screened in age 
and gender, but had a significantly lower FEVi-predicted (83 
versus 97%; P < 0.001), lower vital capacity, lower FEVi and a 
significantly higher reversibility (10% versus 3% \ P <  0.001).
Prevalence of asthma/COPD in 1992
The total p reva lence  o f as thm a/C O PD  (g rades  1-5) was 
306/1000 screened (Table 4). The prevalence for each of the 10 
practices varied from 210/1000 to 420/1000 (Table 5). Most 
cases were mild (grades 1 and 2: prevalence of 203/1000).
(■mm
Table 2. Number of subjects involved in the surveys in 1977 and 
1992. In 1992,1155 subjects were screened and 29 were exclud­
ed from screening because of the use of inhaled corticosteroids.
1992 1977
Sample size 1988 4623
Excluded from screening 239 0
Number of persons invited 1749 4623
Number of participants 1184 4342
Number of adult participants (age 25-70) 1184 2328
Table 3. A comparison of patient characteristics within the 1992 
survey: the 1155 patients screened were considered for this 
analysis. Patients using medication (non-corticosteroid) at the 
time of the screening versus the rest. The standard deviations 
have been presented within parentheses.
Patient characteristics Using medication Rest
Number 29 1126
Age (years) 43 (13) 43(12)
Sex percentage 
(malerfemale) 38:62 45:55
Vital capacity (ml) 3644 (823)* 4081 (1054)
FEV1 (ml) 2744 (757)* 3253 (838)
FEV1% of predicted 83% (17)* 97% (14)
Reversibility 10.1% (10.3)* 3.1% (3.7)
* P< 0.05.
Table 4. The severity and prevalence of asthma/COPD in 1992 
compared with 1977. The number of cases per grade of severity 
as a percentage of the total prevalence has been presented. The 
percentage of cases not detected in routine care (unknown to 
GP) is also presented.
Distribution 
of cases






Severity 1992 1977 1992 1977 1992 1977
Grades 1-2 203 151 67 79 73 80
Grade 3 68 17 22 9 70 61
Grades 4-5 35 22 11 12 7 31
Total (1-5) 306 190 100 100 65 72
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Table 5. A comparison of the prevalence in 1977 with that of the 10 separate samples (95% Cl) and the aggregated total in 1992. The 
prevalence (practices) and the 95% CIs (presented as a percentage) are given for each sample. The results of the chi-squared test for 












1977 2328 443 19.0 17-21 —
1992:1 215 60 27.9 22-34 0.002
1992: 2 111 31 27.9 19-36 0.019
1992:3 127 40 31.5 23—40 0.001
1992: 4 114 38 33.3 25-42 0.002
1992:5 89 34 38.2 28-49 0.000
1992:6 100 21 21.0 13-29 0.610
1992: 7 106 ‘ 25 23.6 15-32 0.239
1992: 8 109 33 30.3 21-39 0.004
1992: 9 107 45 42.0 33-52 0.000
1992: 10 106 35 33.0 24-42 0.000
1992: 1-10 1184 362 30.6 28-33 0.000
higher than in 1977 (306/1000 versus 190/1000). Table 5 shows 
that eight out of the 10 practices screened in 1992 had a signifi­
cantly higher prevalence than the practice in 1977. The main rea­
son for this increase in prevalence is an increase in mild to mod­
erate forms of asthma and COPD (grades 1-3). The prevalence 
of grades 1-3 has increased from ' 168/1000 in 1977 to 271/1000 
in 1992 (Table 4). Out of the 362 cases identified in the 1992 
survey, 35% had previously been diagnosed in routine general 
practice compared with only 28% of the cases in 1977. This was 
particularly true for the most severe cases (93 versus 69%).
Discussion
In this study, we compared the results of a population survey on 
asthma and COPD, conducted in 10 general practices in 1992, 
with the results of a survey in one practice in 1977. This study 
indicates an increase in the prevalence of asthma/COPD from 
1977 to 1992. The main reason for this is an increase in the 
prevalence of mild to moderate asthma and COPD (grades 1-3). 
A substantial number of cases found during the survey had not 
been picked-up in routine patient care. In 1992 and in 1977, most 
of the more severe cases had already been detected. There is a 
trend towards greater detection in recent years (especially of the 
more severe cases), and this may point to greater asthma (and 
COPD) awareness.
For all ages, population surveys have reported a prevalence of 
10-30%. In general practice morbidity registration, preva­
lences of 30/1000 are consistently given.14' 16 This same discrep­
ancy between cases present in the population (screening) and 
identified in routine general practice care (presented morbidity) 
came forward from this study.
The prevalence of asthma and COPD are influenced by the age 
and gender of the population, cigarette smoking, social class, 
urbanization, and probably the level of air pollution. These fac­
tors will have influenced the comparison made in this study. The 
surveys of 1977 and 1992 were held under comparable condi­
tions in the same suburban region of the east of the Netherlands. 
The majority of patients in both surveys were working class. The 
patients in 1992 had been recruited from practices other than the 
one involved in the 1977 survey, and therefore, the 1977 results 
will not have influenced the awareness of their general practi­
tioner of undetected asthma/COPD. Selective participation could 
not be demonstrated in the 1992 survey, and in 1977, the com­
plete population of one general practice had been invited for par­
ticipation, of whom 90% completed both stages of the survey.
What could not be controlled for was the influence of active (and
4
passive) smoking. It is likely that the national trend for a modest 
reduction in smoking in the past decade will also have been 
applicable to this region. Conversely, the levels of air pollution 
(motorized traffic and industrialization) have increased since 
1977. In comparing morbidity between general practices, it is 
important to take into account practice routines, as these may be 
a source of bias of reported/registered morbidity. A comparison 
of proportions (prevalence) between the practice in 1977, and the 
10 practices in 1992 separately, shows that eight practices had a 
significantly higher prevalence than in 1977. Five per cent of the 
practices could be expected to differ significantly because of 
chance. In our study, 80% of the practices differed significantly 
from  that in 1977; therefore, it is highly unlikely that this 
increase was caused by chance. This study was based on prac­
tices  affilia ted  w ith  the D epartm ent o f  G eneral Practice, 
University of Nijmegen. The practice involved in the 1977 sur­
vey had played a predominant role in morbidity registration since 
1967, and had developed a routine in the diagnostic labelling of 
presented morbidity at the time of the 1977 survey. This proba­
bly will have fac ilita ted  the d iagnosis  o f  asthm a/C O PD . 
Therefore, the percentage of patients unknown was probably 
lower than in the average general practice of 1977. The practices 
of the 1992 survey were practices of the Department of General 
Practice in Nijmegen. These practices had been previously 
involved in a series of studies on asthma and COPD with special 
emphasis on early diagnosis and long-term follow-up.10,17 Again, 
this will probability have enhanced the number of cases of asth­
ma/COPD under care. Although it is important to be cautious 
when comparing morbidity rates between different practices, our 
data represent, in our opinion, an optimum in this respect: the 
information of patients diagnosed with asthma/COPD in super­
vised ‘academic’ general practice in 1977 and 1992. The 1992 
survey was held outside the practice area involved in the 1977 
survey, and therefore, the results were not directly influenced by 
the 1977 survey. However, as it was performed in the same 
region of the country, in our view, it is correct to compare these 
data and to conclude a trend towards an increased prevalence of 
asthma/COPD with, at the same time, a somewhat higher propor­
tion of cases already detected in routine patient care.
Our study shows that the ‘iceberg’ of asthma/COPD consists 
mainly of patients with mild symptoms. However, there are, 
some patients with undetected symptoms and/or lung function 
deficits (grades 3-4). The patients under maintenance treatment 
with inhaled corticosteroids were included in the analysis.
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However, it was not possible to assess the severity of the disease 
in these patients as the corticosteroid treatment will have influ­
enced signs, symptoms and spirometric performance. Therefore, 
these patients were excluded from the initial screening. Inclusion 
of these patients in the most severe grade of disease was, in our 
perception, justified but arbitrary. It was reassuring that no new 
patients with a serious form of the disease (grade 5) were identi­
fied during screening: thus, all severe cases were positioned in 
the tip of the ‘iceberg’. More attention should be paid to patients 
of mild and moderate severity. Our study did not address the 
question of why cases detected at screening had not been diag­
nosed before in routine general practice care. It is important to 
stress the fact that this is a controversial point: there is no evi­
dence available to this group that early and preventive care will 
improve the long-term outcome of the disease—evidence that is 
already available for more severe grades of asthma/COPD.17 As a 
consequence of this, there is no scientific basis to promote early 
presentation, detection and treatment of mild cases. It is our 
objective to pursue this question in a follow-up of this study: all 
patients who are found to be in need of treatment will be invited 
for a randomized, double-blind, placebo-controlled trial to study 
the effectiveness of inhaled corticosteroids for such patients 
detected by means of a screening survey.
One of the reported reasons for under-presentation of asthma 
is that people get accustomed to symptoms and do not find it 
necessary to consult the general practitioner.'7 In that particular 
case, the general practitioners cannot be blamed for the fact that 
a high percentage of patients remain unknown to them. However, 
it is very important that patients who do consult the general prac­
titioner for their symptoms are diagnosed and properly treated. 
From our data, it can be inferred that general practitioners are 
more aware of asthma/COPD: a higher proportion of severe 
cases had been detected in 1992 compared with 1977. Our con­
tacts with the subjects during screening gave a strong suggestion 
that those with respiratory abnormalities had only seldom con­
sulted their general practitioner for these problems, indicating 
under-reporting of symptoms. The subjects already under treat­
ment had significant but mild spirometric abnormalities.
We conclude that there is a real increase in the prevalence of 
asthma and COPD. Of these patients, nearly all of the most 
severe cases have been diagnosed in routine patient care, Less- 
severe cases form the majority of patients, and despite an overall 
increase of cases identified in daily (general) practice care, the 
percentage not known to the GP has remained high. Greater 
insight is mandatory for effective early intervention in this group 
before sound recommendations can be made to improve early 
diagnosis of these patients.
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PARTNERSHIPS IN PRACTICE - 
DEVELOPING OCCUPATIONAL THERAPY 
SERVICES IN PRIMARY CARE
Wednesday 15 May 1996 
Venue: Royal College of General Practitioners, 
14 Princes Gate, London SW7
This Conference, being organised jointly by the College of 
Occupational Therapist» and the Royal College of General 
Practitioners, will explore the development of occupational 
therapy services within a Primary Care Led NIIS. The 
Conference will be opened by Her Royal Highness the Princess 
Royal. This event will bring general practitioners, occupational 
therapists and others together to consider, at a strategic and 
service delivery level, the needs of practice populations for 
occupational therapy. Existing models of good practice will also 
be highlighted. PGEA Applied for.
For further details please contact: Natasha Watson, Conference 
Department, College o f Occupational Therapists, 6 Marshalsea 
Road, London SKI M L
Tel: 0171 357 6480 Fax: 0171 403 3991
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